#USA #Veeva Systems #Pleasanton #Health Care #AI Agents

Veeva Systems Unveils AI Agents for Its Applications in 2025

Veeva Systems, a leading provider in cloud solutions for the life sciences industry, has announced that advanced AI agents will soon be integrated into its suite of applications, beginning in December 2025. This initiative is set to revolutionize the way businesses operate across various sectors, enabling significant improvements in productivity and efficiency.

The Vision Behind Veeva AI

According to Peter Gassner, CEO of Veeva, the introduction of AI agents aligns with their goal to enhance innovation within the pharmaceutical industry. Gassner stated, "AI will fundamentally change the way drugs are developed and how treatment decisions are made in care centers. Our aim with Veeva AI is to significantly boost innovation and productivity, ensuring that better medicines reach more patients faster."

The AI agents, designed to address industry-specific use cases, will be integrated into Veeva Vault, providing contextual understanding, specific prompts, and protective measures suitable for each application. With direct and secure access to data, documents, and workflows within Veeva's applications, these agents are poised to optimize the overall user experience.

Rollout Schedule and Capabilities

Starting in December 2025, the initial rollout will include functionalities critical to customer relationship management and content generation. The first phase will be followed by further updates in 2026, targeting areas such as quality assurance, clinical operations, regulatory compliance, and clinical data management. This process ensures that all major sectors are equipped with AI tools tailored to meet their operational needs, enhancing overall performance.

Projected Availability Timeline

• - December 2025: Customer relationship management and content generation.
• - April 2026: Security and quality assurance functionalities.
• - August 2026: Clinical operations and regulatory compliance.
• - December 2026: Clinical data management and related features.

Advanced Technology and Customization Options

The AI agents will utilize advanced language models (LLMs) from Anthropic and Amazon, hosted on the Amazon Bedrock platform. Additionally, users will have the option to create customized agents using either Veeva's hosted models or their own, spanning services from Amazon Bedrock to Microsoft Azure AI Foundry. This flexibility allows clients to tailor the AI's functionalities to best fit their unique requirements.

Furthermore, Veeva AI's pricing model is designed to lower barriers to entry, enabling clients to scale their usage as their needs evolve. The focus on usage-based pricing reflects Veeva's commitment to accessibility and client satisfaction.

Conclusion

Veeva Systems is setting the stage for a new era in the life sciences industry, where AI-driven solutions will facilitate faster, more efficient processes across multiple sectors. This strategic move not only emphasizes Veeva's innovative approach but also reinforces its mission to improve patient access to vital medications. As we approach the rollout dates, industry stakeholders are eagerly anticipating the transformative impact of Veeva AI on their operational landscapes.

For more information and continuous updates on Veeva AI, clients can visit the Veeva AI Community on Veeva Connect. Veeva continues to demonstrate its commitment to not just technological advancement but to the broader health of the industry as a whole.